Cargando…
Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infants
BACKGROUND: The optimal treatment regimen or protocol for managing a persistent patent ductus arteriosus (PDA) in extremely low birth weight (ELBW) infants has not been well established. This study was aimed at evaluating the failure rate of a cyclooxygenase (COX) inhibitor (COI) for PDA closure and...
Autores principales: | Adrouche-Amrani, Lynda, Green, Robert S, Gluck, Karen M, Lin, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293740/ https://www.ncbi.nlm.nih.gov/pubmed/22284694 http://dx.doi.org/10.1186/1471-2431-12-10 |
Ejemplares similares
-
Does it exist pulmonary hypertension in the ELBW infants?
por: Dani, Carlo
Publicado: (2015) -
Duct stenting in an ELBW infant with aortic arch interruption
por: Anagnostopoulou, Andriana S., et al.
Publicado: (2022) -
Obstetrical risk factors of ELBW
por: Rizzo, Nicola, et al.
Publicado: (2015) -
The Effect of Red Blood Cell Transfusion on Intermittent Hypoxemia in ELBW Infants
por: Jawdeh, Elie G. Abu, et al.
Publicado: (2014) -
Congenital skin aplasia on the lower limb in a premature infant with ELBW – case report
por: Pająk, Agata, et al.
Publicado: (2014)